The new SPAC aims to combine with a life sciences target, particularly a company that applies machine learning techniques and structure-based drug design to improve the therapeutic development process. JATT is led by CEO Dr. Someit Sidhu, COO Tauhid Ali, PhD, and CFO Verender S. Badial.
Total SPAC deal count for 2021 year-to-date is now 369. This offering is expected to close on Friday, July 16.
Raymond James & Associates, Inc. is the sole book-running manager for the IPO. Loeb & Loeb LLP is serving as Issuer’s Counsel with Ellenoff Grossman & Schole LLP serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.